What is the detection window for MDMA (3,4‑methylenedioxymethamphetamine) in blood and urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MDMA Detection Windows

MDMA can be detected in blood for approximately 2-12 hours after use, while urine detection extends to 1.5-4 days after a single dose, and up to 1 week in chronic users 1, 2.

Blood Detection

Blood testing provides the shortest detection window but correlates best with acute impairment. Blood concentrations are most useful for detecting drug use that occurred within 2 to 12 hours of testing 1. Research confirms that MDMA and its primary metabolite MDA reach peak plasma concentrations at 2 hours post-dose, with detectable levels (>20 ng/mL for MDMA and >40 ng/mL for HMMA) still present at 24 hours, but typically falling below detection limits by 96 hours 3, 4.

Key Blood Detection Points:

  • Peak concentrations: 2-4 hours after ingestion
  • Practical detection window: 2-12 hours for clinical purposes
  • Extended detection: Up to 24 hours in some cases, but unreliable beyond this
  • Blood testing requires specialized personnel and is invasive, making it rarely used outside emergency settings 1

Urine Detection

Urine testing provides a significantly longer detection window and is the most commonly used specimen for drug testing 1. After a single dose, MDMA and its metabolites can be detected for 1.5-4 days, with chronic users showing positive results for approximately 1 week after last use 2.

Key Urine Detection Points:

  • Single dose: 1.5-4 days detection window
  • Chronic use: Approximately 1 week after last use
  • Peak urinary concentrations: MDMA peaks at 4 hours, MDA at 8 hours, HMMA at 12 hours, and HMA at 16 hours post-dose 3
  • Extended detection: MDMA and metabolites can remain detectable (>25 ng/mL) for up to 168 hours (7 days) in research settings 3

The primary metabolites detected in urine are conjugated HMMA and HHMA, which represent the main urinary excretion products 4. Urine testing is well-standardized, less invasive than blood testing, and provides the longer detection window needed for most clinical and forensic applications 1.

Alternative Matrices

While not specifically requested, it's worth noting that:

  • Saliva/oral fluid: Detects recent use within 24-48 hours, similar to blood 1, 2
  • Sweat patches: Can detect use for 48 hours before application and during the 3-7 day wear period 1, 5
  • Hair: Provides 90-day detection window but cannot detect use within the previous 7-10 days 1

Clinical Caveats

Important considerations for interpretation:

  • Detection windows vary based on dose, individual metabolism, hydration status, and urine pH 2
  • Immunoassay screening tests may produce false-positives requiring confirmatory testing with gas chromatography-mass spectrometry 1
  • Urine concentration affects detection sensitivity—dilute urine may produce false-negatives 2
  • Co-ingestion of other substances occurs in 85% or more of MDMA-positive cases, most commonly cannabis and alcohol 6

The choice between blood and urine testing depends on the clinical question: use blood for acute impairment assessment in emergency settings, and urine for detecting use over the past several days in outpatient or forensic contexts 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.